Overview
Lobbying Costs
550,000€
Financial year: Oct 2010 - Oct 2011
Lobbyists (Full time equivalent)
None declared
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Genzyme Corporation
EU Transparency Register
2946627525-90 First registered on 17 Oct 2008
Goals / Remit
Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. That goal guides and inspires us every day. Genzyme’s portfolio of transformative therapies, which are marketed in countries around the world, represents groundbreaking and life-saving advances in medicine. As a Sanofi company, Genzyme benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
Main EU files targeted
Address
Head Office
Kendall Street
Cambridge MA 02142
UNITED STATES -
People
Total lobbyists declared
None declared
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
None declared
Person with legal responsibility
Ms Vinciane Pirard (Director Public Affairs)
-
Categories
Category
II - In-house lobbyists and trade/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Oct 2010 - Oct 2011
Lobbying costs for closed financial year
550,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
None declared
Communication activities
None declared
Other activities
None declared
Meetings
Meetings
None declared